Clinical Trial Update: Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care [NA]

View source ↗

Summary

Clinical trial comparing Cytal Wound Matrix 1-Layer to standard of care for diabetic foot ulcers was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Diabetic Foot

Drugs mentioned

• Cytal Wound Matrix 1-Layer

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Diabetes, Diabetic Foot | NA | Status: TERMINATED | Results posted: 2021-02-15